Short answer
RIGEL PHARMACEUTICALS INC (RIGL) filed an 8-K current report with the SEC on May 20, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item 5.07 (Submission of Matters to a Vote of Security Holders). Stockholders approved 500,000 additional shares under Rigel’s 2018 Equity Incentive Plan.
RIGEL PHARMACEUTICALS INC 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Stockholders approved 500,000 additional shares under Rigel’s 2018 Equity Incentive Plan
- Increased equity capacity supports employee and executive compensation but may dilute existing shareholders
- Stockholders approved 360,000 additional shares under the 2000 Employee Stock Purchase Plan
- Both amended plans became effective immediately on May 14, 2026
Item 5.07 · Submission of Matters to a Vote of Security Holders
- All three director nominees elected through 2029; Alison Hannah received 9,202,113 votes for versus 1,469,709 withheld
- Amended 2018 Equity Incentive Plan approved narrowly, with 6,497,964 for versus 3,813,701 against
- Amended 2000 Employee Stock Purchase Plan approved decisively, with 9,840,922 votes for
- Executive compensation approved advisory, with 9,013,480 votes for and 1,291,609 against
- Ernst & Young ratified for fiscal 2026, with 12,590,773 votes for; no broker non-votes reported
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other RIGEL PHARMACEUTICALS INC 8-K filings
Get the next RIGL 8-K as it lands
Follow RIGL for push alerts, or ask the research agent what this filing means.